The Utility of [P16.Sup.Ink4a] in Discriminating Between Cervical Intraepithelial Neoplasia 1 and Nonneoplastic Equivocal Lesions of the Cervix (Original Articles) (Report)

The Utility of [P16.Sup.Ink4a] in Discriminating Between Cervical Intraepithelial Neoplasia 1 and Nonneoplastic Equivocal Lesions of the Cervix (Original Articles) (Report)

Current literature suggests that the protein [p16.sup.Ink4a] may be used as a biomarker for the identification of cervical intraepithelial neoplasia (CIN) as well as a test to decrease interobserver variability in making the diagnosis of CIN lesions. (1-9) [p16.sup.Ink4a] is a cell-cycle regulatory protein that negatively influences cell proliferation through a reciprocal relationship with another tumor suppressor protein, retinoblastoma gene product (pRb). (1,5) The action of pRb is to inhibit cells from entering the S phase of the cell cycle and proliferating. (5) It is modified via phosphorylation by cyclin D1 complexed with other cyclin-dependent kinases (cdk 4 through 6). (1-3,5) In the presence of the human papillomavirus (HPV) oncoprotein E7, pRb is inactivated. (5) This inactivation of pRb allows for the transcription of genes required for DNA replication and the inappropriate shifting of the cell cycle past the G1/S restriction point into the S phase. (2-3-5) As pRb is functionally inactivated by HPV oncoprotein E7, there is a reciprocal overexpression of [p16.sup.Ink4a]. (1-3,5) Marked overexpression of the [p16.sup.Ink4a] protein can be demonstrated immunohistochemically using monoclonal antibodies. Studies of cervical carcinomas and preneoplastic lesions of the cervix resulting from high-risk human papillomavirus (HR-HPV) subtypes, specifically subtypes 16 and 18, have demonstrated a strong and diffuse nuclear and cytoplasmic immunoreactivity of [p16.sup.Ink4a] in these lesions. (2,3,5,8-10) Subtypes 16 and 18 are representative of HR-HPV and are the most clinically important HPV subtypes because infection by these subtypes is associated with an increased risk of cervical carcinoma. (2,4) Cervical lesions associated with low-risk HPV subtypes, specifically HPV 6 and 11, express focal and weak [p16.sup.Ink4a] immunohistochemical reactivity and are not associated with an increased risk of cervical carcinoma. (2,8,9)

The Utility of [P16.Sup.Ink4a] in Discriminating Between Cervical Intraepithelial Neoplasia 1 and Nonneoplastic Equivocal Lesions of the Cervix (Original Articles) (Report)

Here is Download Link

Epithelial Hyperplastic Lesions Of The Larynx


Epithelial Hyperplastic Lesions Of The Larynx Download Now Read Online

Author by : Nina Gale
Languange Used : en
Release Date : 1995
Publisher by : Elsevier Science Limited






Burghardt S Colposcopy And Cervical Pathology


Burghardt S Colposcopy And Cervical Pathology Download Now Read Online

Author by : Frank Girardi
Languange Used : en
Release Date : 2015-03-25
Publisher by : Thieme






Mechanisms Of Oncogenesis


Mechanisms Of Oncogenesis Download Now Read Online

Author by : Domenico Coppola
Languange Used : en
Release Date : 2010-03-17
Publisher by : Springer Science & Business Media






Neuroendocrine Tumors Review Of Pathology Molecular And Therapeutic Advances


Neuroendocrine Tumors Review Of Pathology Molecular And Therapeutic Advances Download Now Read Online

Author by : Aejaz Nasir
Languange Used : en
Release Date : 2016-08-31
Publisher by : Springer






Breast Cancer Risk Reduction And Early Detection


Breast Cancer Risk Reduction And Early Detection Download Now Read Online

Author by : Edward R. Sauter
Languange Used : en
Release Date : 2010-01-22
Publisher by : Springer Science & Business Media






Molecular Applications In Cytology


Molecular Applications In Cytology Download Now Read Online

Author by : Fernando C. Schmitt
Languange Used : en
Release Date : 2018-07-24
Publisher by : Springer






Colposcopy Cervical Pathology


Colposcopy Cervical Pathology Download Now Read Online

Author by : Erich Burghardt
Languange Used : en
Release Date : 1991
Publisher by : Thieme Medical Pub






Leave a Reply

Your email address will not be published. Required fields are marked *